Hosted by Dr. Peter M. Kovacs · 🇺🇸 US · EN-US · 18 episodes
Established thought leaders with verified media credentials.
Welcome to Clinical Capital Conversations! Join host Dr. Peter M. Kovacs, a clinical research pioneer and global investor, as he explores the intersection of science and strategic investment. Discover what it takes to transform medical innovation into scalable impact.Each episode features unfiltered conversations with clinical research leaders, biotech/medtech founders, VCs, and policymakers. Peter shares his firsthand experience, from building agile clinical trial networks to investing in disruptive health tech across Asia and Europe.
Dr. Peter M. Kovacs hosts Clinical Capital Conversations, a business show with 18 episodes published.
FemTech is often framed as a market trend. In this episode of “Clinical Capital Conversations”, Dr. Peter M. Kovacs explains why it is actually a long-overdue clinical correction. Together with Roswitha Verwer, Founder a
In this episode of Clinical Capital Conversations, Dr. Peter M. Kovacs sits down with Roswitha Verwer (YONE) and Karoly Szanto to unpack what most investors miss in early-stage health innovation: execution is the moat. Y
This is a continuation of our main conversation on what it takes to turn medical innovation into scalable impact. In this episode, Dr. Peter M. Kovacs sits down with Károly Szántó and Thijmen Meijer to unpack the co-inve
Europe has elite science. Asia has a capital. So why do so many European university spinouts never reach venture readiness or exits? In this episode, Dr. Peter M. Kovacs speaks with Károly Szántó and Thijmen Meijer about
In this episode of Clinical Capital Conversations, Dr. Peter M. Kovacs speaks with Károly Szántó about venture studios, calculated risk, and what it really takes to turn promising innovation into execution. We cover: How
In this episode of Clinical Capital Conversations, Dr. Peter M. Kovacs and Pavlina Walter speak with Michaela Hrdlickova about Age Management and why workforce execution risk is one of the most overlooked variables in he
In this episode of Clinical Capital Conversations, Dr. Peter M. Kovacs and Pavlina Walter speak with Ales Vavra, a former hedge fund manager known for exposing weaknesses in overhyped biotech companies. Together, they ex
AI memory therapy is no longer a concept. It is here, clinically validated, and already helping dementia patients feel less lonely and more connected. In this episode of Clinical Capital Conversations, Peter M. Kovacs sp
Inside Europe, a new type of hospital is emerging. In this episode of Clinical Capital Conversations, Dr. Peter M. Kovacs and Pavlina Walter sit down with Antonín Hlavinka, the innovation and digitalization lead at Unive
Can artificial intelligence bring us closer instead of pulling us apart? In this episode of Clinical Capital Conversations, Dr. Peter M. Kovacs and Pavlina Walter speak with Vassili Le Moigne, founder of InTouch, about h
Biologics are transforming medicine, but who’s enabling that transformation behind the scenes? In this episode, I sit down with Jiri Raska, Chief Commercial Officer at Quinta Analytica, and Pavlina Walter, to discuss: Wh
In this episode of Clinical Capital Conversations, I sat down with Pavlina Walter and our guest Jiri Pavlíček, a mentor, entrepreneur, and one of Central Europe’s most respected MedTech leaders. Together, we explored eve
In this episode, Peter M. Kovacs speaks with Károly Szántó and Thijmen Meijer, co-founders of Uniprisma, about how Central Europe’s startup scene is maturing from ideas to execution. They discuss founder psychology, team
In this episode, Peter M. Kovacs speaks with Roswitha Verwer and Dr. Muskaan Bhan, the founders of YON E Health, about transforming personal trauma into global innovation. They discuss the journey from idea to clinical-g
What will decide the future of AI in Europe: ethics, bureaucracy, or competitiveness? In this episode, I sit down with Jan Kavalírek, Deputy Minister of Industry and Trade and Government Envoy for AI in the Czech Republi
Who We Are: PMK Group and Our Mission in Biotech | Clinical Capital Conversations Biotech often fails for the wrong reasons. Nearly 60% of clinical trial failures are due to technical execution, not the science itself. I
What does real AI adoption in healthcare look like when you leave the hype behind? In this Prague Episode, I speak with Lukas Benzel, Managing Director of the Czech Association of Artificial Intelligence, and Pavlina Wal
In this episode, Dr. Peter M. Kovacs shares the story of how a study trip in 2018 transformed his life. Within weeks, he decided to relocate his family to Singapore, a country that would become both his home and the stra
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
To pitch Clinical Capital Conversations, visit https://podcasters.spotify.com/pod/show/dr-peter-m-kovacs for contact information, then craft a tight one-paragraph hook that ties your expertise to a gap in their recent business coverage.
Clinical Capital Conversations is hosted by Dr. Peter M. Kovacs. The show is categorised under business and has published 18 episodes.
Clinical Capital Conversations has published 18 episodes.
Clinical Capital Conversations regularly covers business. It sits in the business category.
Clinical Capital Conversations is accessible for guests with genuine business expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Clinical Capital Conversations hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Clinical Capital Conversations average 30 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Clinical Capital Conversations's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 9 days ago.
